BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17012119)

  • 1. Evaluation of the performance of a new continuous spheronizer.
    Pinto JF; Abreu CN
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1067-78. PubMed ID: 17012119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight P
    Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between micromeritic properties of mixing powders of danshen extract and formability of their pellets].
    Xtong ZW; Luo Y; Liao ZG; Zhao GW; Li Z; Luo J
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4317-23. PubMed ID: 25850259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on the co-extrudability and spheronization properties of wet masses.
    Pinto JF; Lameiro MH; Martins P
    Int J Pharm; 2001 Oct; 227(1-2):71-80. PubMed ID: 11564542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M; Thommes M
    Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM; Heng PW
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scale-up of the rounding process in pelletization by extrusion-spheronization.
    Evers M; Weis D; Antonyuk S; Thommes M
    Pharm Dev Technol; 2019 Oct; 24(8):1014-1020. PubMed ID: 31232624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two commercial brands of microcrystalline cellulose for extrusion-spheronization.
    Law MF; Deasy PB; McLaughlin JP; Gabriel S
    J Microencapsul; 1997; 14(6):713-23. PubMed ID: 9394252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of load on particle size distribution of lactose-crystalline cellulose mixed powder.
    Nakamori T; Miyagishim A; Nozawa Y; Sadzuka Y; Sonobe T
    Int J Pharm; 2008 Apr; 354(1-2):255-9. PubMed ID: 18258396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protocol for the classification of wet mass in extrusion-spheronization.
    Gao Y; Hong Y; Xian J; Lin X; Shen L; Zhang X; Zhang N; Feng Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):996-1005. PubMed ID: 23563104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pelletization mechanism by extrusion/spheronization.
    Koester M; Thommes M
    AAPS PharmSciTech; 2010 Dec; 11(4):1549-51. PubMed ID: 21042960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization.
    Mallipeddi R; Saripella KK; Neau SH
    Int J Pharm; 2010 Jan; 385(1-2):53-65. PubMed ID: 19853027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.